TSPO PIGA Ligands Promote Neurosteroidogenesis and Human Astrocyte Well-Being

International Journal of Molecular Sciences

Volumn 17, Issue 7, 2016, Pages

  Da Pozzo, Eleonora ^a   Giacomelli, Chiara ^a   Costa, Barbara ^a   Cavallini, Chiara ^a   Taliani, Sabrina ^a   Barresi, Elisabetta ^a   Da Settimo, Federico ^a   Martini, Claudia ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Astrocytes; Cellular proliferation; Neurosteroidogenesis; Oxidative metabolism; PIGA ligands; Translocator protein

Indexed keywords

7 CHLORO 2 (3 PYRIDYL) ALPHA TETRALONE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; N,N DIALKYL 2 PHENYLINDOL 3 YLGLYOXYLAMIDE; NEUROSTEROID; PREGNENOLONE; TRANSLOCATOR PROTEIN 18 KDA; TRILOSTANE; UNCLASSIFIED DRUG; INDOLE DERIVATIVE; N,N-DI-N-BUTYL-5-CHLORO-2-(4-CHLOROPHENYL)INDOL-3-YLGLYOXYLAMIDE;

AEROBIC METABOLISM; ANIMAL CELL; ARTICLE; ASTROCYTE; BIOSYNTHESIS; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; DISSOCIATION RATE CONSTANT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LIGAND BINDING; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NONHUMAN; RAT; STEROIDOGENESIS; CELL LINE; CYTOLOGY; DRUG EFFECTS; METABOLISM; OXIDATION REDUCTION REACTION;

ASTROCYTES; CELL LINE; CELL PROLIFERATION; HUMANS; INDOLES; NEUROGENESIS; OXIDATION-REDUCTION; PREGNENOLONE;

EID: 84976591482     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17071028     Document Type: Article

References (87)

1. Rupprecht, R.; Holsboer, F. Neuroactive steroids: Mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci. 1999, 9, 410–416. [CrossRef]
2. Reddy, D.S. Neurosteroids: Endogenous role in the human brain and therapeutic potentials. Prog. Brain Res. 2010, 186, 113–137. [PubMed]
3. Pfaff, D.W.; Gerlach, J.L.; McEwen, B.S.; Ferin, M.; Carmel, P.; Zimmerman, E.A. Autoradiographic localization of hormone-concentrating cells in the brain of the female rhesus monkey. J. Comp. Neurol. 1976, 170, 279–293. [CrossRef][PubMed]
4. Buisson, B.; Bertrand, D. Steroid modulation of the nicotinic acetylcholine receptor. In Neurosteroids: A New Regulatory Function in the Nervous System, 1999th ed.; Baulieu, E.E., Robel, P., Schumacher,M., Eds.; Humana Press: Totowa, NJ, USA, 1999.
5. Gibbs, T.T.; Yaghoubi, N.; Weaver, C.E., Jr.; Park-Chung, M.; Russek, S.J.; Farb, D.H. Modulation of ionotropic glutamate receptors by neuroactive steroids. In Neurosteroids: A New Regulatory Function in the Nervous System, 1999th ed.; Baulieu, E.E., Robel, P., Schumacher, M., Eds.; Humana Press: Totowa, NJ, USA, 1999; pp. 167–190.
6. Majewska, M.D. Neurosteroid antagonists of the GABAA receptors. In Neurosteroids: A New Regulatory Function in the Nervous System, 1999th ed.; Baulieu, E.E., Robel, P., Schumacher, M., Eds.; Humana Press: Totowa, NJ, USA, 1999; pp. 155–166.
7. Bastianetto, S.; Ramassamy, C.; Poirier, J.; Quirion, R. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Mol. Brain Res. 1999, 6, 35–41. [CrossRef]
8. Gee, K.W.; McCaule, L.D.; Lan, N.C. A putative receptor for neurosteroids on the GABAA receptor complex: The pharmacological properties and therapeutic potential of epalons. Crit. Rev. Neurobiol. 1995, 9, 207–227. [PubMed]
9. Ueda, H.; Yoshida, A.; Tokuyama, S.; Mizuno, K.; Maruo, J.; Matsuno, K.; Mita, S. Neurosteroids stimulate G protein-coupled sigma receptors in mouse brain synaptic membrane. Neurosci. Res. 2001, 41, 33–40. [CrossRef]
10. Schlichter, R.; Keller, A.F.; de Roo, M.; Breton, J.D.; Inquimbert, P.; Poisbeau, P. Fast nongenomic effects of steroids on synaptic transmission and role of endogenous neurosteroids in spinal pain pathways. J. Mol. Neurosci. 2006, 28, 33–51. [CrossRef]
11. Herd, M.B.; Belelli, D.; Lambert, J.J. Neurosteroid modulation of synaptic and extrasynaptic GABA(A) receptors. Pharmacol. Ther. 2007, 116, 20–34. [CrossRef][PubMed]
12. Magnaghi, V. GABA and neuroactive steroid interactions in glia: New roles for old players? Curr. Neuropharmacol. 2007, 5, 47–64. [CrossRef][PubMed]
13. Duenas, M.; Luquin, S.; Chowen, J.A.; Torres-Aleman, I.; Naftolin, F.; Garcia-Segura, L.M. Gonadal hormone regulation of insulin-like growth factor-I-like immunoreactivity in hypothalamic astroglia of developing and adult rats. Neuroendocrinology 1994, 59, 528–538. [CrossRef][PubMed]
14. Kirschner, P.B.; Henshaw, R.; Weise, J.; Trubetskoy, V.; Finklestein, S.; Schulz, J.B.; Beal, M.F. Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats. J. Cereb. Blood Flow Metab. 1995, 15, 619–623. [CrossRef][PubMed]
15. Stone, D.J.; Rozovsky, I.; Morgan, T.E.; Anderson, C.P.; Hajian, H.; Finch, C.E. Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp. Neurol. 1997, 143, 313–318. [CrossRef][PubMed]
16. Flores, C.; Salmaso, N.; Cain, S.; Rodaros, D.; Stewart, J. Ovariectomy of adult rats leads to increased expression of astrocytic basic fibroblast growth factor in the ventral tegmental area and in dopaminergic projection regions of the entorhinal and prefrontal cortex. J. Neurosci. 1999, 19, 8665–8673. [PubMed]
17. Buchanan, C.D.; Mahesh, V.B.; Brann, D.W. Estrogen-astrocyte-luteinizing hormone-releasing hormone signaling: A role for transforming growth factor- ˜1. Biol. Reprod. 2000, 62, 1710–1721. [CrossRef][PubMed]
18. Galbiati, M.; Martini, L.; Melcangi, R.C. Oestrogens, via transforming growth factor —, modulate basic fibroblast growth factor synthesis in hypothalamic astrocytes: In vitro observations. J. Neuroendocrinol. 2002, 14, 829–835. [CrossRef][PubMed]
19. Kazanis, I.; Giannakopoulou, M.; Philippidis, H.; Stylianopoulou, F. Alterations in IGF-I, BDNF and NT-3 levels following experimental brain trauma and the effect of IGF-I administration. Exp. Neurol. 2004, 186, 221–234. [CrossRef][PubMed]
20. Platania, P.; Seminara, G.; Aronica, E.; Troost, D.; Vincenza Catania, M.; Angela Sortino, M. 17˜-estradiol rescues spinal motoneurons from AMPA-induced toxicity: A role for glial cells. Neurobiol. Dis. 2005, 20, 461–470. [CrossRef][PubMed]
21. Mendez, P.; Cardona-Gomez, G.P.; Garcia-Segura, L.M. Interactions of insulin-like growth factor-I and estrogen in the brain. Adv. Exp. Med. Biol. 2005, 567, 285–303. [PubMed]
22. Dhandapani, K.M.; Brann, D.W. Role of astrocytes in estrogen-mediated neuroprotection. Exp. Gerontol. 2007, 42, 70–75. [CrossRef][PubMed]
23. Cerciat, M.; Unkila, M.; Garcia-Segura, L.M.; Arevalo, M.A. Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro. Glia 2010, 58, 93–102. [CrossRef][PubMed]
24. Xu, S.L.; Bi, C.W.; Choi, R.C.; Zhu, K.Y.; Miernisha, A.; Dong, T.T.; Tsim, K.W. Flavonoids induce the synthesis and secretion of neurotrophic factors in cultured rat astrocytes: A signaling response mediated by estrogen receptor. Evid. Based Complement. Altern. Med. 2013, 2013. [CrossRef][PubMed]
25. Spence, R.D.; Wisdom, A.J.; Cao, Y.; Hill, H.M.; Mongerson, C.R.; Stapornkul, B.; Itoh, N.; Sofroniew, M.V.; Voskuhl, R.R. Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ER˜ signaling on astrocytes but not through ER˜ signaling on astrocytes or neurons. J. Neurosci. 2013, 33, 10924–10933. [CrossRef][PubMed]
26. Lee, E.; Sidoryk-Wêgrzynowicz, M.; Wang, N.; Webb, A.; Son, D.S.; Lee, K.; Aschner, M. GPR30 regulates glutamate transporter GLT-1 expression in rat primary astrocytes. J. Biol. Chem. 2012, 287, 26817–26828. [CrossRef][PubMed]
27. Araújo, G.W.; Beyer, C.; Arnold, S. Oestrogen influences on mitochondrial gene expression and respiratory chain activity in cortical and mesencephalic astrocytes. J. Neuroendocrinol. 2008, 20, 930–941.
28. Irwin, R.W.; Yao, J.; Hamilton, R.T.; Cadenas, E.; Brinton, R.D.; Nilsen, J. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 2008, 149, 3167–3175. [CrossRef][PubMed]
29. Morohaku, K.; Pelton, S.H.; Daugherty, D.J.; Butler, W.R.; Deng, W.; Selvaraj, V. Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology 2014, 155, 89–97. [CrossRef][PubMed]
30. Tu, L.N.; Morohaku, K.; Manna, P.R.; Pelton, S.H.; Butler, W.R.; Stocco, D.M.; Selvaraj, V. Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. J. Biol. Chem. 2014, 289, 27444–27454. [CrossRef][PubMed]
31. Banati, R.B.; Middleton, R.J.; Chan, R.; Hatty, C.R.; Kam, W.W.; Quin, C.; Graeber, M.B.; Parmar, A.; Zahra, D.; Callaghan, P. et al. Positron emission tomography and functional characterization of a complete PBR/TSPO knockout. Nat. Commun. 2014, 5. [CrossRef][PubMed]
32. Papadopoulos, V.; Lecanu, L. Translocator protein (18 kDa) TSPO: An emerging therapeutic target in neurotrauma. Exp. Neurol. 2009, 219, 53–57. [CrossRef][PubMed]
33. Frye, C.A. Neurosteroids’ effects and mechanisms for social, cognitive, emotional, and physical functions. Psychoneuroendocrinology 2009, 34, S143–S161. [CrossRef][PubMed]
34. Fan, J.; Campioli, E.; Midzak, A.; Culty, M.; Papadopoulos, V. Conditional steroidogenic cell-targeted deletion of TSPO Unveils a Crucial role in Viability and Hormone-Dependent Steroid Formation. Proc. Natl. Acad. Sci. USA 2015, 112, 7261–7266. [CrossRef][PubMed]
35. Mellon, S.H.; Deschepper, C.F. Neurosteroid biosynthesis: Genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res. 1993, 629, 283–292. [CrossRef]
36. King, S.R.; Ginsberg, S.D.; Ishii, T.; Smith, R.G.; Parker, K.L.; Lamb, D.J. The steroidogenic acute regulatory protein is expressed in steroidogenic cells of the day-old brain. Endocrinology 2004, 145, 4775–4780. [CrossRef][PubMed]
37. Papadopoulos, V.; Baraldi, M.; Guilarte, T.R.; Knudsen, T.B.; Lacapère, J.J.; Lindemann, P.; Norenberg, M.D.; Nutt, D.; Weizman, A.; Zhang, M.R. et al. Translocator protein (18 kDa): New nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 2006, 27, 402–409. [CrossRef][PubMed]
38. Lacapère, J.J.; Papadopoulos, V. Peripheral-type benzodiazepine receptor: Structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids 2003, 68, 569–585. [CrossRef]
39. Da Pozzo, E.; Costa, B.; Martini, C. Translocator protein (TSPO) and neurosteroids: Implications in psychiatric disorders. Curr. Mol. Med. 2012, 12, 426–442. [CrossRef][PubMed]
40. Da Pozzo, E.; Giacomelli, C.; Barresi, E.; Costa, B.; Taliani, S.; da Settimo, F.; Martini, C. Targeting the 18 kDa translocator protein: Recent perspectives for neuroprotection. Biochem. Soc. Trans. 2015, 43, 559–565. [CrossRef][PubMed]
41. Veiga, S.; Azcoitia, I.; Garcia-Segura, L.M. Ro5-4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity. J. Neurosci. Res. 2005, 80, 129–137. [CrossRef][PubMed]
42. Veiga, S.; Carrero, P.; Pernia, O.; Azcoitia, I.; Garcia-Segura, L.M. Translocator protein 18 kDa is involved in the regulation of reactive gliosis. Glia 2007, 55, 1426–1436. [CrossRef][PubMed]
43. Girard, C.; Liu, S.; Cadepond, F.; Adams, D.; Lacroix, C.; Verleye, M.; Gillardin, J.M.; Baulieu, E.E.; Schumacher, M.; Schweizer-Groyer, G. Etifoxine improves peripheral nerve regeneration and functional recovery. Proc. Natl. Acad. Sci. USA 2008, 105, 20505–20510. [CrossRef][PubMed]
44. Zhao, Y.Y.; Yu, J.Z.; Li, Q.Y.; Ma, C.G.; Lu, C.Z.; Xiao, B.G. TSPO-specific ligand vinpocetine exerts a neuroprotective effect by suppressing microglial inflammation. Neuron Glia Biol. 2011, 7, 187–197. [CrossRef][PubMed]
45. Santoro, A.; Mattace Raso, G.; Taliani, S.; da Pozzo, E.; Simorini, F.; Costa, B.; Martini, C.; Laneri, S.; Sacchi, A.; Cosimelli, B. et al. TSPO-ligands prevent oxidative damage and inflammatory response in C6 glioma cells by neurosteroid synthesis. Eur. J. Pharm. Sci. 2016, 88, 124–131. [CrossRef][PubMed]
46. Costa, B.; da Pozzo, E.; Giacomelli, C.; Barresi, E.; Taliani, S.; da Settimo, F.; Martini, C. TSPO ligand residence time: A new parameter to predict compound neurosteroidogenic efficacy. Sci. Rep. 2016, 6. [CrossRef][PubMed]
47. Chen, J.H.; Tsou, T.C.; Chiu, I.M.; Chou, C.C. Proliferation inhibition, DNA damage, and cell-cycle arrest of human astrocytoma cells after acrylamide exposure. Chem. Res. Toxicol. 2010, 23, 1449–1458. [CrossRef][PubMed]
48. Li, Y.; Cheng, D.; Cheng, R.; Zhu, X.; Wan, T.; Liu, J.; Zhang, R. Mechanisms of U87 astrocytoma cell uptake and trafficking of monomeric versus protofibril Alzheimer’s disease amyloid-˜ proteins. PLoS ONE 2014, 9, e99939. [CrossRef][PubMed]
49. Maresca, B.; Spagnuolo, M.S.; Cigliano, L. Haptoglobin modulates ˜-amyloid uptake by U-87 MG astrocyte cell line. J. Mol. Neurosci. 2015, 56, 35–47. [CrossRef][PubMed]
50. Munoz, L.; Kavanagh, M.E.; Phoa, A.F.; Heng, B.; Dzamko, N.; Chen, E.J.; Doddareddy, M.R.; Guillemin, G.J.; Kassiou, M. Optimisation of LRRK2 inhibitors and assessment of functional efficacy in cell-based models of neuroinflammation. Eur. J. Med. Chem. 2015, 95, 29–34. [CrossRef][PubMed]
51. Da Settimo, F.; Simorini, F.; Taliani, S.; La Motta, C.; Marini, A.M.; Salerno, S.; Bellandi, M.; Novellino, E.; Greco, G.; Cosimelli, B. et al. Anxiolytic-like effects of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesis. J. Med. Chem. 2008, 51, 5798–5806. [CrossRef][PubMed]
52. Barresi, E.; Bruno, A.; Taliani, S.; Cosconati, S.; da Pozzo, E.; Salerno, S.; Simorini, F.; Daniele, S.; Giacomelli, C.; Marini, A.M. et al. Deepening the topology of the Translocator Protein binding site by novel N,N-dialkyl-2-arylindol-3-ylglyoxylamides. J. Med. Chem. 2015, 58, 6081–6092. [CrossRef][PubMed]
53. Kugler, W.; Veenman, L.; Shandalov, Y.; Leschiner, S.; Spanier, I.; Lakomek, M.; Gavish, M. Ligands of the mitochondrial 18 kDa translocator protein attenuate apoptosis of human glioblastoma cells exposed to erucylphosphohomocholine. Cell Oncol. 2008, 30, 435–450. [PubMed]
54. Banfalvi, G. Cell Cycle Synchronization. Methods and Protocols; Humana Press: Totowa, NJ, USA, 2011.
55. Chen, M.; Huang, J.; Yang, X.; Liu, B.; Zhang, W.; Huang, L.; Deng, F.; Ma, J.; Bai, Y.; Lu, R.; Huang, B.; Gao, Q.; Zhuo, Y.; Ge, J. Serum starvation induced cell cycle synchronization facilitates human somatic cells reprogramming. PLoS ONE 2012, 7, e28203. [CrossRef][PubMed]
56. Takahashi, S.; Abe, T.; Gotoh, J.; Fukuuchi, Y. Substrate-dependence of reduction of MTT: A tetrazolium dye differs in cultured astroglia and neurons. Neurochem. Int. 2002, 40, 441–448. [CrossRef]
57. Dunigan, D.D.; Waters, S.B.; Owen, T.C. Aqueous soluble tetrazolium/formazan MTS as an indicator of NADH- and NADPH-dependent dehydrogenase activity. Biotechniques 1995, 19, 640–649. [PubMed]
58. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55–63. [CrossRef]
59. Papadopoulos, V.; Guarneri, P.; Kreuger, K.E.; Guidotti, A.; Costa, E. Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: Regulation by a mitochondrial diazepam binding inhibitor receptor. Proc. Natl. Acad. Sci. USA 1992, 89, 5113–5117. [CrossRef][PubMed]
60. Azcoitia, I.; Sierra, A.; Veiga, S.; Garcia-Segura, L.M. Aromatase expression by reactive astroglia is neuroprotective. Ann. N. Y. Acad. Sci. 2003, 1007, 298–305. [CrossRef][PubMed]
61. Groeneveld, G.J.; van Muiswinkel, F.L.; Sturkenboom, J.M.; Wokke, J.H.; Bär, P.R.; van den Berg, L.H. Ovariectomy and 17˜-estradiol modulate disease progression of a mouse model of ALS. Brain Res. 2004, 1021, 128–131. [CrossRef][PubMed]
62. Garcia-Ovejero, D.; Azcoitia, I.; Doncarlos, L.L.; Melcangi, R.C.; Garcia-Segura, L.M. Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones. Brain Res. Rev. 2005, 48, 273–286. [CrossRef][PubMed]
63. Conejo, N.M.; González-Pardo, H.; Cimadevilla, J.M.; Argüelles, J.A.; Díaz, F.; Vallejo-Seco, G.; Arias, J.L. Influence of gonadal steroids on the glial fibrillary acidic protein-immunoreactive astrocyte population in young rat hippocampus. J. Neurosci. Res. 2005, 79, 488–494. [CrossRef][PubMed]
64. Barreto, G.; Veiga, S.; Azcoitia, I.; Garcia-Segura, L.M.; Garcia-Ovejero, D. Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: Role of its metabolites, oestradiol and dihydrotestosterone. Eur. J. Neurosci. 2007, 25, 3039–3046. [CrossRef][PubMed]
65. Choi, C.I.; Lee, Y.D.; Gwag, B.J.; Cho, S.I.; Kim, S.S.; Suh-Kim, H. Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice. J. Neurol. Sci. 2008, 268, 40–47. [CrossRef][PubMed]
66. Garcia-Segura, L.M. Hormones and Brain Plasticity; Oxford University Press: New York, NY, USA, 2009.
67. Arevalo, M.A.; Santos-Galindo, M.; Bellini, M.J.; Azcoitia, I.; Garcia-Segura, L.M. Actions of estrogens on glial cells: Implications for neuroprotection. Biochim. Biophys. Acta 2010, 1800, 1106–1112. [CrossRef][PubMed]
68. Gandolfo, P.; Patte, C.; Thoumas, J.L.; Leprince, J.; Vaudry, H.; Tonon, M.C. The endozepine ODN stimulates [3H]thymidine incorporation in cultured rat astrocytes. Neuropharmacology 1999, 38, 725–732. [CrossRef]
69. Gandolfo, P.; Patte, C.; Leprince, J.; Régo, J.L.; Mensah-Nyagan, A.G.; Vaudry, H.; Tonon, M.C. The triakontatetraneuropeptide (TTN) stimulates thymidine incorporation in rat astrocytes through peripheral-type benzodiazepine receptors. J. Neurochem. 2000, 75, 701–707. [CrossRef][PubMed]
70. Neary, J.T.; Jorgensen, S.L.; Oracion, A.M.; Bruce, J.H.; Norenberg, M.D. Inhibition of growth factor-induced DNA synthesis in astrocytes by ligands of peripheral-type benzodiazepine receptors. Brain Res. 1995, 675, 27–30. [CrossRef]
71. Bruce, J.H.; Ramirez, A.M.; Lin, L.; Oracion, A.; Agarwal, R.P.; Norenberg, M.D. Peripheral-type benzodiazepines inhibit proliferation of astrocytes in culture. Brain Res. 1991, 564, 167–170. [CrossRef]
72. Ikezaki, K.; Black, K.L. Stimulation of cell growth and DNA synthesis by peripheral benzodiazepine. Cancer Lett. 1990, 49, 115–120. [CrossRef]
73. Miccoli, L.; Oudard, S.; Beurdeley-Thomas, A.; Dutrillaux, B.; Poupon, M.F. Effect of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide (PK11195), a specific ligand of the peripheral benzodiazepine receptor, on the lipid fluidity of mitochondria in human glioma cells. Biochem. Pharmacol. 1999, 58, 715–721. [CrossRef]
74. Shiraishi, T.; Black, K.L.; Ikezaki, K.; Becker, D.P. Peripheral benzodiazepine induces morphological changes and proliferation of mitochondria in glioma cells. J. Neurosci. Res. 1991, 30, 463–474. [CrossRef][PubMed]
75. Black, K.L.; Shiraishi, T.; Ikezak, K.; Tabuchi, K.; Becker, D.P. Peripheral benzodiazepine stimulates secretion of growth hormone and mitochondrial proliferation in pituitary tumour GH3 cells. Neurol. Res. 1994, 16, 74–80. [PubMed]
76. Scarf, A.M.; Auman, K.M.; Kassiou, M. Is there any correlation between binding and functional effects at the translocator protein (TSPO) (18 kDa)? Curr. Mol. Med. 2012, 12, 387–397. [CrossRef][PubMed]
77. Alho, H.; Varga, V.; Krueger, K.E. Expression of mitochondrial benzodiazepine receptor and its putative endogenous ligand diazepam binding inhibitor in cultured primary astrocytes and C-6 cells: Relation to cell growth. Cell Growth Differ. 1994, 5, 1005–1014. [PubMed]
78. Gao, Z.W.; Huang, J.B.; Lin, Q.; Qin, Q.; Liang, Y.J.; Zhou, L.; Luo, M. The effects of PK11195 on meningioma was associated with allopregnanolone biosynthesis, which was mediated by translocator protein 18 kDa. Cancer Biomark. 2016, 16, 65–69. [CrossRef][PubMed]
79. Hechter, O.; Halkerston, I.D. Effects of steroid hormones on gene regulation and cell metabolism. Annu. Rev. Physiol. 1965, 27, 133–162. [CrossRef][PubMed]
80. Takuma, K.; Baba, A.; Matsuda, T. Astrocyte apoptosis: Implications for neuroprotection. Prog. Neurobiol. 2004, 72, 111–127. [CrossRef][PubMed]
81. Wagner, B.; Natarajan, A.; Grünaug, S.; Kroismayr, R.; Wagner, E.F.; Sibilia, M. Neuronal survival depends on EGFR signaling in cortical but not midbrain astrocytes. EMBO J. 2006, 25, 752–762. [CrossRef][PubMed]
82. Bauer, J.; Elger, C.E.; Hans, V.H.; Schramm, J.; Urbach, H.; Lassmann, H.; Bien, C.G. Astrocytes are a specific immunological target in Rasmussen’s encephalitis. Ann. Neurol. 2007, 62, 67–80. [CrossRef][PubMed]
83. Ricci, G.; Volpi, L.; Pasquali, L.; Petrozzi, L.; Siciliano, G. Astrocyte-neuron interactions in neurological disorders. J. Biol. Phys. 2009, 35, 317–336. [CrossRef][PubMed]
84. Wingerchuk, D.M. Neuromyelitis optica spectrum disorders. Continuum (Minneap. Minn.) 2010, 16, 105–121. [CrossRef][PubMed]
85. Escartin, C.; Rouach, N. Astroglial networking contributes to neurometabolic coupling. Front. Neuroenerg. 2013, 5. [CrossRef][PubMed]
86. Najjar, S.; Pearlman, D.M.; Alper, K.; Najjar, A.; Devinsky, O. Neuroinflammation and psychiatric illness. J. Neuroinflamm. 2013, 10. [CrossRef][PubMed]
87. Phatnani, H.; Maniatis, T. Astrocytes in neurodegenerative disease. Cold Spring Harb. Perspect. Biol. 2015, 7. [CrossRef][PubMed]